Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1.

Παρόμοια τεκμήρια

• Enhancement of Cellular Immunity in Melanoma Patients Immunized with a Peptide from MART-1/Melan A
  ανά: Cormier, Janice N., κ.ά.
  Έκδοση: (1997)
• Culture of Melanoma Cells in 3-Dimensional Architectures Results in Impaired Immunorecognition by Cytotoxic T Lymphocytes Specific for Melan-A/MART-1 Tumor-Associated Antigen
  ανά: Ghosh, Sourabh, κ.ά.
  Έκδοση: (2005)
• Identification of an HLA-DPB1*0501 Restricted Melan-A/MART-1 Epitope Recognized by CD4(+) T Lymphocytes: Prevalence for Immunotherapy in Asian Populations
  ανά: Meng, Zhaoting, κ.ά.
  Έκδοση: (2011)
• Melan-A/MART-1(51–73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells
  ανά: Zarour, Hassane M., κ.ά.
  Έκδοση: (2000)
• Autoantibodies in vitiligo patients are not directed to the melanocyte differentiation antigen MelanA/MART1
  ανά: Waterman, E A, κ.ά.
  Έκδοση: (2002)